Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2025 | Evaluating the four-tier hybrid grading system in Ta NMIBC

Ludovica Cella, MD, Humanitas University, Milan, Italy, discusses findings from a study assessing the prognostic performance of a four-tier hybrid grading system in Ta non–muscle-invasive bladder cancer (NMIBC). By integrating elements of the WHO 1973 and 2004 classifications, this hybrid approach demonstrated enhanced ability to differentiate patient outcomes related to disease progression and recurrence. These findings support its value in improving diagnostic clarity and informing tailored management strategies in NMIBC. This interview took place at the 2025 European Association of Urology (EAU) Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.